In 2023, neoplasms mortality in Brazil stood at 116.20 thousand female deaths. The forecasted data shows a steady increase in female mortality due to neoplasms from 2024 to 2028, with an annual growth rate indicating a year-on-year increase ranging between 1.58% and 1.83%. The compound annual growth rate (CAGR) over the five-year forecasted period from 2024 to 2028 is approximately 1.78%, suggesting a consistent rise in mortality numbers.
Looking forwards, factors influencing future trends include potential advancements in cancer treatment, changes in healthcare policies within Brazil, and public health initiatives focused on cancer prevention and early detection. Monitoring these elements will be crucial in understanding future deviations from current projections.
